Yibo Hua

462 total citations
23 papers, 289 citations indexed

About

Yibo Hua is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yibo Hua has authored 23 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yibo Hua's work include Circular RNAs in diseases (4 papers), Smart Grid Energy Management (3 papers) and Epigenetics and DNA Methylation (3 papers). Yibo Hua is often cited by papers focused on Circular RNAs in diseases (4 papers), Smart Grid Energy Management (3 papers) and Epigenetics and DNA Methylation (3 papers). Yibo Hua collaborates with scholars based in China and India. Yibo Hua's co-authors include Jianzhong Zhang, Chao Liang, Aiming Xu, Chenkui Miao, Jundong Zhu, Zengjun Wang, Shifeng Su, Chao Qin, Meiling Bao and Yiyang Liu and has published in prestigious journals such as Scientific Reports, Medicine and BioMed Research International.

In The Last Decade

Yibo Hua

20 papers receiving 286 citations

Peers

Yibo Hua
Yibo Hua
Citations per year, relative to Yibo Hua Yibo Hua (= 1×) peers Haruko Kunitomi

Countries citing papers authored by Yibo Hua

Since Specialization
Citations

This map shows the geographic impact of Yibo Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibo Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibo Hua more than expected).

Fields of papers citing papers by Yibo Hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibo Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibo Hua. The network helps show where Yibo Hua may publish in the future.

Co-authorship network of co-authors of Yibo Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Yibo Hua. A scholar is included among the top collaborators of Yibo Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibo Hua. Yibo Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
5.
Zhou, Chuang, et al.. (2024). Research on distribution–microgrid-coupled network demand response based on a multi-time scale. Frontiers in Energy Research. 12.
6.
Hua, Yibo, et al.. (2024). Analysis of Hemorrhagic Shock Following Percutaneous Nephrolithotomy Resulting from Diaphragm Injury: A Case Report. Archivos Españoles de Urología. 77(4). 446–446. 1 indexed citations
7.
Hua, Yibo, Chao Liang, Jie Yang, et al.. (2022). Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor.. PubMed. 14(2). 1051–1059. 2 indexed citations
8.
Dong, Shufeng, et al.. (2022). Control Configuration Based on AOE and Its Application in the Power Allocation of BESSs. 635–639. 1 indexed citations
9.
Huang, Zhengkai, Yibo Hua, Ye Tian, et al.. (2018). High expression of fructose-bisphosphate aldolase�A induces progression of renal cell carcinoma. Oncology Reports. 39(6). 2996–3006. 28 indexed citations
10.
Hua, Yibo, Chao Liang, Chenkui Miao, et al.. (2018). MicroRNA‑126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. Oncology Letters. 15(6). 9051–9060. 38 indexed citations
11.
Yu, Yajie, Chao Liang, Shangqian Wang, et al.. (2018). CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinoma. Oncotarget. 9(17). 13313–13323. 12 indexed citations
12.
Zhu, Jundong, Chao Liang, Yibo Hua, et al.. (2017). The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma. Oncotarget. 8(31). 51559–51568. 22 indexed citations
13.
Miao, Chenkui, Chao Liang, Ye Tian, et al.. (2017). Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma. Oncotarget. 8(58). 97811–97821. 16 indexed citations
14.
Miao, Chenkui, Chao Liang, Jundong Zhu, et al.. (2017). Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis. Oncotarget. 8(19). 32309–32321. 39 indexed citations
15.
Miao, Chenkui, Kai Zhao, Jundong Zhu, et al.. (2017). Clinicopathological and Prognostic Role of Long Noncoding RNA Linc00152 in Various Human Neoplasms: Evidence from Meta-Analysis. BioMed Research International. 2017. 1–11. 4 indexed citations
16.
Hua, Yibo, Chao Liang, Jundong Zhu, et al.. (2017). Expression of lactate dehydrogenase C correlates with poor prognosis in renal cell carcinoma. Tumor Biology. 39(3). 3726131196–3726131196. 29 indexed citations
17.
Xu, Aiming, Yibo Hua, Jianzhong Zhang, et al.. (2016). Abnormal Hypermethylation of the VDAC2 Promoter is a Potential Cause of Idiopathic Asthenospermia in Men. Scientific Reports. 6(1). 37836–37836. 21 indexed citations
18.
Qin, Zhiqiang, Xiao Li, Yajie Yu, et al.. (2016). Association between insulin-like growth factor-binding protein-3 polymorphism -202 A/C and the risk of prostate cancer: a meta-analysis. OncoTargets and Therapy. Volume 9. 5451–5459. 6 indexed citations
19.
Yu, Yajie, Xiao Li, Chao Liang, et al.. (2016). The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility. Medicine. 95(37). e4900–e4900. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026